Kodiak Sciences Inc
KOD
NASDAQ
Biotechnology
$41.35
USD
+1.37 (+3.43%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.53B
Volume 746.9K
About Kodiak Sciences Inc
The company is headquartered in Palo Alto, California and currently employs 124 full-time employees. The company went IPO on 2018-10-04.
CEO
Dr. Victor Perlroth
HQ
Palo Alto, CALIFORNIA, US
Founded
2018
Employees
124
Key Metrics
2 metrics our research team weighs before forming a view on KOD.
Based on Quantli research · SEC filings · as of Q1 2026
METRIC
VALUE
CHANGE
TREND (3Y)
ROE (TTM)
-205.8%
-30.6 pp
Free Cash Flow (TTM)
$-148.12M
—
Financial Snapshot
Revenue
$0
— YoY
Gross Margin
—
— YoY
Net Income
$-230.66M
-21.0%
YoY
Operating Cash Flow
$-146.94M
-37.6%
YoY
Key Statistics
Open
$37.40
Previous Close
$39.98
Day Range
$36.35 - $42.00
52 Week Range
$8.29 - $47.84
Volume
746.9K
Average Volume (10 Days)
560.0K
Dividend Yield
—
Valuation Measurement
Market Cap
$2.53B
P/E Ratio (TTM)
—
Price / Book
22.56
Financial Highlights
Return on Assets
-75.4%
Return on Equity
-205.8%
Revenue (TTM)
$0
Net Income (TTM)
$-230.66M
Diluted EPS (TTM)
-$4.17
Total Cash (MRQ)
$169.53M
Levered FCF (TTM)
$-148.12M
Turn research into action
Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.
Similar Stocks
BEAM
Beam Therapeutics Inc
$26.75
▲ +0.9%
NRIX
Nurix Therapeutics Inc
$27.05
▼ -0.5%
SLS
Sellas Life Sciences Group Inc
$12.78
▲ +3.4%
BCRX
BioCryst Pharmaceuticals Inc
$9.74
▼ -0.7%
CDNA
CareDx Inc
$45.32
▼ -4.3%
COAG
Hemab Therapeutics Holdings Inc
$54.94
▲ +1.8%
VERA
Vera Therapeutics, Inc
$31.63
▲ +9.5%
RARE
Ultragenyx Pharmaceutical Inc
$26.49
▲ +0.4%
KLRA
Kailera Therapeutics Inc
$17.94
▼ -0.2%
Earnings Calendar
Next Earnings
Estimated Q2 Release
Aug 19
Est. EPS
Adjusted consensus estimate
-$0.97